This study aimed to verify the possible influence of apolipoproteinB (ApoB: rs1042031 and rs693) and angiotensin-converting enzyme(ACE-ID: rs1799752) genotypes on the lipid profile andfunctional aerobic capacity, respectively, after an aerobic interval training(AIT) program in patients with CAD and/or cardiovascular risk factors. The gene discussed is ACE; the disease is coronary artery disorder.